Hypera | Sustainability Performance
A pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare and consumer wellness products.
2001
Brazil
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3080
Overallⓘ#62
in Brazilⓘ#73
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsCarbon certificatesEnergy consumptionWaste ManagementWater ManagementNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Critical
Aligned
Laggard
Intensity
Energy consumption (direct) intensity (MWh /$M)
Water consumption intensity (m³ /$M)
Industry Benchmark
138.0
B/M 65.5
145.9
B/M 121.5
Powered by illuminem and GIST Impact
Controversy level
- Hypera SA, Brazilian major pharma (Joao Alves de Queiroz Filho/Igarapava founded), has faced sustained Brazilian ANVISA enforcement scrutiny over the historic 20242025 sustained Hypera Brazil sales practices investigations affecting institutional shareholders, plus periodic Brazilian CVM enforcement scrutiny on alleged inadequate disclosure of Brazilian pharma customer demand affecting Brazilian institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.